Nabriva Therapeutics Plc
Officers & Directors
1. Theodore R. Schroeder - Chairman and Chief Executive Officer
Mr. Schroeder has more than 20 years of experience in the pharmaceutical industry. Prior to joining Nabriva, he was the co-founder, President, and CEO of Cadence Pharmaceuticals, which was acquired by Mallinckrodt in 2014.
2. Jennifer Schranz - Chief Medical Officer
Dr. Schranz has over 20 years of clinical research experience. Before joining Nabriva, she was the Chief Medical Officer of AiCuris, a German biopharmaceutical company.
3. Gary Sender - Chief Financial Officer
Mr. Sender has over 25 years of experience in finance and capital management. Prior to joining Nabriva, he was the Chief Financial Officer at Otonomy, a biopharmaceutical company focused on developing treatments for ear diseases.
4. Robert R. Lapenta - Executive Director
Mr. Lapenta is the founder and Chairman of Revolution Lighting Technologies, Inc. He is also a co-founder and partner of Aston Capital LLC.
5. Colin Broom - Non-Executive Director
Dr. Broom is a pharmaceutical executive with more than 25 years of experience in drug development. He has held senior positions at several large pharmaceutical companies, including Pfizer and AstraZeneca.
6. Will Sargent - Non-Executive Director
Mr. Sargent has over 20 years of experience in the pharmaceutical industry. He currently serves as Corporate Vice President, Global Franchise Head for Respiratory and Dermatology at Astellas Pharma.
Nabriva Therapeutics Plc currently has 40 employees.
|
